• Dansk
  • Ελληνικά
  • Français

Sitemap

  • Patient
    • What is cystinosis?
    • Symptoms
    • Diagnosis
    • Living with cystinosis
    • Quick facts
    • Tools and resources
  • HCP
    • Disease background
    • Identifying symptoms
    • Diagnosing cystinosis
    • General management
    • Clinical recommendations
    • HCP tools and resources
  • Privacy Policy
  • Cookies
  • Terms of use
  • Sitemap

The information on this website is intended only to provide knowledge of cystinosis disease health topics. This information should not be used in place of advice from your GP or other healthcare professional. If in doubt, please contact your doctor for advice. This website has been produced by Chiesi Farmaceutici. The website has been developed in accordance with industry and legal standards to provide information for healthcare professionals and patients about cystinosis disease health topics. Chiesi Farmaceutici makes every reasonable effort to include accurate and current information. However, the information provided in this website is not exhaustive.

Acknowledgements
Chiesi Farmaceutici extend special thanks to Cystinosis Network Europe (CNE), at http://cystinosis-europe.eu for their insightful review of the contents.
CNE received no honorarium or payment for this review.

ALL_21_071 | November 2022

©2025 CHIESI Farmaceutici S.p.A. – VAT 01513360345, Company's Capital: Euro 75.000.000, Companies Register Office – Parma N.15739, REA: 159271

Privacy Policy Cookies Terms of use Sitemap

Follow us on:

Patients & Caregivers: in case of need to report an adverse drug reaction, please refer to your physician, asking him to fill in and submit the relevant case report to the concerned Health Authority, according to the Pharmacovigilance requirements in force in your Country. Nevertheless, please be kindly reminded that each patient can report any such cases directly to the national reporting system.

Healthcare Professionals: in case you want to report an adverse drug reaction you become aware of, please report it to your Health Authority according to the requirements set by the pharmacovigilance legislation.